Aspirin Global Market Report 2023

“Aspirin Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aspirin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aspirin? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The aspirin market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Prescription; OTC

• 2) By Route Of Administration: Oral; Rectal; Parenteral

• 3) By Dosage Form: Tablets; Capsules; Injections; Suppositories

• 4) By Application: Cardiovascular Disease; Pain, Fever, O Inflammation; Other Applications

• 5) By End User: Hospitals; Clinics; Other End Users

• Companies Mentioned: Bayer AG; Allegiant Health; Par Pharmaceutical; Cardinal Health, Inc.; Nanjing pharmaceutical factory Co. Ltd.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the aspirin market are Bayer AG, Allegiant Health, Par Pharmaceutical, Cardinal Health, Inc., Nanjing pharmaceutical factory Co. Ltd., JQC (Huayin) Pharmaceutical Co., Ltd., LNK International, Inc., Bal Pharma Limited, Trumac Healthcare, Perrigo Company PLC, Alta Laboratories Ltd., Zhenjiang Gaopeng Pharmaceutical Co., Ltd., J.M. Loveridge Ltd., Mayne Pharma Group Limited and St. Joseph's Aspirin.

The global aspirin market is expected to grow from $2.36 billion in 2022 to $2.45 billion in 2023 at a compound annual growth rate (CAGR) of 4.14%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The aspirin market is expected to grow to $2.92 billion in 2027 at a CAGR of 4.41%.

The aspirin market consists of sales of capsules, chewable, and coated tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Aspirin is a non-steroidal anti-inflammatory drug used to treat fever and minor aches. The chemical name of aspirin is acetylsalicylic acid (ASA). It is used for treating conditions such as arthritis and to reduce the chance of problems like heart attack and stroke.

Asia-Pacific was the largest region in the aspirin market in 2022. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The two major types of product of aspirin are prescription and OTC. Prescription drugs are drugs that can only be bought through a certified physician's prescription. By route of administration, it is segmented into oral, rectal, and parenteral. Several dosage forms of aspirin are tablets, capsules, injections, and suppositories. Aspirin is used in numerous applications, such as cardiovascular disease, pain, fever, inflammation, and others. These are used by various end-users, such as hospitals, clinics, and other end-users.

The increasing prevalence of arthritis is expected to propel the growth of the aspirin market going forward. Arthritis is a medical condition in which a patient suffers from pain and swelling in the joints. Aspirin is a nonsteroidal anti-inflammatory medicine that helps people with chronic pain from arthritis and other conditions by reducing inflammation, reducing pain, and improving function. Increasing arthritis patients directly increases the use of aspirin. For instance, according to a report shared by the Centers for Disease Control and Prevention, a US-based national public health agency, 1 in 4 adults in the US were suffering from doctor-diagnosed arthritis, which is almost 58.5 million people. The number is expected to increase to 78.4 million by 2040. As a result, the increasing prevalence of arthritis is driving the growth of the aspirin market.

Product innovation is a key trend gaining popularity in the aspirin market. Major companies operating in the aspirin market are introducing innovative products such as VAZALORE™ liquid-filled aspirin capsules to sustain their position in the market. For instance, in August 2021, PLx Pharma, a US-based specialty pharmaceutical company, launched VAZALORE™ 325 mg and VAZALORE™ 81 mg liquid-filled aspirin capsules. The new product is the first US FDA-approved liquid-filled aspirin capsule and is beneficial in avoiding stomach erosions and ulcers as compared to immediate-release aspirin. VAZALORE is an innovative aspirin with a special delivery method created to protect the stomach, even while cardiologists continue to advise aspirin for their patients with cardiovascular disease. Compared to aspirin formulations that are enteric-coated and plain, VAZALORE delivers aspirin differently. Aspirin is released selectively from the capsule's unique complex, avoiding direct contact with the stomach. VAZALORE provides aspirin's potentially life-saving properties along with quick, dependable pain relief absorption.

In August 2021, Philip Morris International (PMI), Inc., a US-based tobacco company, acquired OtiTopic for an undisclosed amount. This acquisition is a part of PMI's strategic objective to expand its pipeline of inhaled therapies and respiratory medication delivery Beyond Nicotine by utilizing its knowledge, scientific know-how, and inhalation capabilities. OtiTopic is a US-based respiratory drug development company with a late-stage inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction. OtiTopic is a developer of an inhaled formulation of aspirin dry powder.

The countries covered in the aspirin market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The aspirin market research report is one of a series of new reports from The Business Research Company that provides aspirin market statistics, including aspirin industry global market size, regional shares, competitors with a aspirin market share, detailed aspirin market segments, market trends and opportunities, and any further data you may need to thrive in the aspirin industry. This aspirin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.